There's new evidence that two inexpensive generic drugs can improve survival rates for women who develop breast cancer after menopause.
In two large studies published Friday in The Lancet, a class of hormone-therapy drugs called aromatase inhibitors and bone-preserving drugs called bisphosphonates improved survival and recurrence rates in postmenopausal women with early breast cancer.
read more: http://www.cbsnews.com/news/two-generic-drugs-shown-to-reduce-breast-cancer-deaths-after-menopause/
No comments:
Post a Comment